Skip to main content
. 2021 May 24;22(1):556. doi: 10.3892/ol.2021.12817

Figure 1.

Figure 1.

827/IcoR and PC9/IcoR cells are resistant to icotinib. (A) Cell viabilities were measured using MTT in parent cells (HCC827 and PC9) and resistant cells (827/IcoR and PC9/IcoR) treated with icotinib for 24 and 48 h. (B) Colony formation was performed to test the effects of icotinib on parent cells (HCC827 and PC9) and resistant cells (827/IcoR and PC9/IcoR). *P<0.05 and **P<0.01. IcoR, icotinib-resistant.